Genetic Testing Labs: Seize the Moment!
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
The analysis of more than 1,000 mouse models of cancer has challenged their ability to predict patient’ response to therapy.
Spark Therapeutic’s Luxturna, a gene therapy for a rare, genetic form of blindness, will be reviewed by a U.S. Food and Drug Administration panel this week.
Scientists have engineered a new way to deliver CRISPR technology inside cells by repairing the mutation that causes Duchenne muscular dystrophy.
The first gene therapy for cancer, approved by the FDA in August, will transform the treatment process, but it will bring both hope and challenges.
Researchers claim that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
A French start-up has urged the development of more powerful drugs to combat antibiotic-resistant diseases, with its new drug, Eligobiotics.
A genetic fault has been identified in people with an aggressive type of leukemia that can significantly affect how they respond to treatment.
A high-speed method has been developed that produces small proteins for custom-designed therapeutics, that may have applications in fighting disease agents.
Scientists have used a genetic engineering technique in a three-generation family with Tourette syndrome, to determine what causes the disease.